MYOMO INC (MYO) Stock Fundamental Analysis

NYSEARCA:MYO • US62857J2015

0.8203 USD
+0.01 (+0.87%)
At close: Feb 13, 2026
0.8101 USD
-0.01 (-1.24%)
After Hours: 2/13/2026, 8:27:34 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

Taking everything into account, MYO scores 3 out of 10 in our fundamental rating. MYO was compared to 186 industry peers in the Health Care Equipment & Supplies industry. MYO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. MYO shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year MYO has reported negative net income.
  • MYO had a negative operating cash flow in the past year.
  • In the past 5 years MYO always reported negative net income.
  • MYO had a negative operating cash flow in each of the past 5 years.
MYO Yearly Net Income VS EBIT VS OCF VS FCFMYO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -24.11%, MYO is in line with its industry, outperforming 49.46% of the companies in the same industry.
  • With a Return On Equity value of -52.93%, MYO perfoms like the industry average, outperforming 50.54% of the companies in the same industry.
Industry RankSector Rank
ROA -24.11%
ROE -52.93%
ROIC N/A
ROA(3y)-58.67%
ROA(5y)-62.8%
ROE(3y)-94.75%
ROE(5y)-92.3%
ROIC(3y)N/A
ROIC(5y)N/A
MYO Yearly ROA, ROE, ROICMYO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

1.3 Margins

  • The Gross Margin of MYO (69.24%) is better than 77.42% of its industry peers.
  • MYO's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for MYO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 69.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.45%
GM growth 5Y2.49%
MYO Yearly Profit, Operating, Gross MarginsMYO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • MYO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, MYO has more shares outstanding
  • The number of shares outstanding for MYO has been increased compared to 5 years ago.
  • MYO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MYO Yearly Shares OutstandingMYO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MYO Yearly Total Debt VS Total AssetsMYO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

  • Based on the Altman-Z score of -2.37, we must say that MYO is in the distress zone and has some risk of bankruptcy.
  • MYO has a Altman-Z score of -2.37. This is comparable to the rest of the industry: MYO outperforms 40.86% of its industry peers.
  • MYO has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of MYO (0.22) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z -2.37
ROIC/WACCN/A
WACC9.7%
MYO Yearly LT Debt VS Equity VS FCFMYO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

  • MYO has a Current Ratio of 2.39. This indicates that MYO is financially healthy and has no problem in meeting its short term obligations.
  • MYO has a Current ratio (2.39) which is comparable to the rest of the industry.
  • MYO has a Quick Ratio of 2.03. This indicates that MYO is financially healthy and has no problem in meeting its short term obligations.
  • MYO has a Quick ratio of 2.03. This is comparable to the rest of the industry: MYO outperforms 55.38% of its industry peers.
Industry RankSector Rank
Current Ratio 2.39
Quick Ratio 2.03
MYO Yearly Current Assets VS Current LiabilitesMYO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • MYO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -26.09%.
  • MYO shows a strong growth in Revenue. In the last year, the Revenue has grown by 69.17%.
  • MYO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 53.36% yearly.
EPS 1Y (TTM)-26.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
Revenue 1Y (TTM)69.17%
Revenue growth 3Y32.93%
Revenue growth 5Y53.36%
Sales Q2Q%9.59%

3.2 Future

  • Based on estimates for the next years, MYO will show a very strong growth in Earnings Per Share. The EPS will grow by 30.48% on average per year.
  • Based on estimates for the next years, MYO will show a very strong growth in Revenue. The Revenue will grow by 24.42% on average per year.
EPS Next Y-117.45%
EPS Next 2Y-31.26%
EPS Next 3Y-3.2%
EPS Next 5Y30.48%
Revenue Next Year32%
Revenue Next 2Y24.53%
Revenue Next 3Y23.5%
Revenue Next 5Y24.42%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
MYO Yearly Revenue VS EstimatesMYO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M 100M
MYO Yearly EPS VS EstimatesMYO Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -50 -100 -150

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • MYO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MYO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MYO Price Earnings VS Forward Price EarningsMYO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MYO Per share dataMYO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

  • MYO's earnings are expected to decrease with -3.20% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-31.26%
EPS Next 3Y-3.2%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for MYO!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MYOMO INC

NYSEARCA:MYO (2/13/2026, 8:27:34 PM)

After market: 0.8101 -0.01 (-1.24%)

0.8203

+0.01 (+0.87%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-10
Earnings (Next)03-09
Inst Owners55.4%
Inst Owner Change-16.06%
Ins Owners7.33%
Ins Owner Change4.04%
Market Cap31.53M
Revenue(TTM)32.55M
Net Income(TTM)-9.32M
Analysts80
Price Target5.1 (521.72%)
Short Float %9.58%
Short Ratio5.01
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3.48%
Min EPS beat(2)-4.22%
Max EPS beat(2)-2.75%
EPS beat(4)2
Avg EPS beat(4)18.06%
Min EPS beat(4)-4.22%
Max EPS beat(4)50.5%
EPS beat(8)4
Avg EPS beat(8)17.38%
EPS beat(12)7
Avg EPS beat(12)14.73%
EPS beat(16)10
Avg EPS beat(16)13.79%
Revenue beat(2)2
Avg Revenue beat(2)5.03%
Min Revenue beat(2)4.48%
Max Revenue beat(2)5.57%
Revenue beat(4)4
Avg Revenue beat(4)10.8%
Min Revenue beat(4)4.48%
Max Revenue beat(4)20.73%
Revenue beat(8)6
Avg Revenue beat(8)6.89%
Revenue beat(12)8
Avg Revenue beat(12)5.03%
Revenue beat(16)12
Avg Revenue beat(16)10.75%
PT rev (1m)0%
PT rev (3m)-1.96%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)3.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.77
P/FCF N/A
P/OCF N/A
P/B 1.79
P/tB 1.79
EV/EBITDA N/A
EPS(TTM)-0.29
EYN/A
EPS(NY)-0.29
Fwd EYN/A
FCF(TTM)-0.33
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS1.06
BVpS0.46
TBVpS0.46
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -24.11%
ROE -52.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 69.24%
FCFM N/A
ROA(3y)-58.67%
ROA(5y)-62.8%
ROE(3y)-94.75%
ROE(5y)-92.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.45%
GM growth 5Y2.49%
F-Score3
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 850.82%
Cap/Sales 7.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.39
Quick Ratio 2.03
Altman-Z -2.37
F-Score3
WACC9.7%
ROIC/WACCN/A
Cap/Depr(3y)269.1%
Cap/Depr(5y)214.88%
Cap/Sales(3y)1.88%
Cap/Sales(5y)1.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
EPS Next Y-117.45%
EPS Next 2Y-31.26%
EPS Next 3Y-3.2%
EPS Next 5Y30.48%
Revenue 1Y (TTM)69.17%
Revenue growth 3Y32.93%
Revenue growth 5Y53.36%
Sales Q2Q%9.59%
Revenue Next Year32%
Revenue Next 2Y24.53%
Revenue Next 3Y23.5%
Revenue Next 5Y24.42%
EBIT growth 1Y1.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-79.42%
EBIT Next 3Y-1.11%
EBIT Next 5YN/A
FCF growth 1Y-71.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-31.3%
OCF growth 3YN/A
OCF growth 5YN/A

MYOMO INC / MYO FAQ

Can you provide the ChartMill fundamental rating for MYOMO INC?

ChartMill assigns a fundamental rating of 3 / 10 to MYO.


What is the valuation status for MYO stock?

ChartMill assigns a valuation rating of 0 / 10 to MYOMO INC (MYO). This can be considered as Overvalued.


Can you provide the profitability details for MYOMO INC?

MYOMO INC (MYO) has a profitability rating of 2 / 10.


Can you provide the financial health for MYO stock?

The financial health rating of MYOMO INC (MYO) is 4 / 10.